TrialArthritis research & therapy2023

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.